多基因负荷对帕金森病纹状体多巴胺能退变的影响
研究基于PPMI数据库335例帕金森病患者,分析多基因负荷与纹状体多巴胺能活性4年纵向变化的关系。结果显示GRS2与纹状体多巴胺能活性下降更慢相关,GRS1则无此关联;GRS1和GRS2均与更年轻的发病年龄相关。提示帕金森病风险遗传因素对纹状体多巴胺能退变的影响可能异质。
要点
- GRS2与纹状体多巴胺能活性下降更慢相关,GRS1无此关联。
- 多基因负荷越高,帕金森病发病年龄可能越年轻。
- 进展特异性遗传风险评分或有助于预测疾病进展。
核心结论
- 帕金森病风险遗传因素对纹状体多巴胺能退变的影响可能异质,部分因素与多巴胺能活性下降更慢相关。
研究设计与样本
- 基于PPMI数据库335例帕金森病患者的纵向研究,使用123I-FP-CIT SPECT评估4年纹状体多巴胺能活性变化。
- 多基因负荷通过加权遗传风险评分GRS1(27个SNP)和GRS2(23个MAF>0.05的SNP)估计。
主要发现
- GRS1与纹状体123I-FP-CIT可用性变化无关联。
- GRS2与纹状体多巴胺能活性下降更慢相关:尾状核估计值0.399,SE 0.165,p=0.028;壳核估计值0.396,SE 0.137,p=0.016。
- GRS1与发病年龄相关:Spearman ρ=-0.128,p=0.019;GRS2与发病年龄相关:Spearman ρ=-0.109,p=0.047。
临床怎么用
- 进展特异性遗传风险评分可能用于预测帕金森病疾病进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the effect of polygenic load on the progression of striatal dopaminergic dysfunction in patients with Parkinson disease (PD). METHODS: Using data from 335 patients with PD in the Parkinson's Progression Markers Initiative (PPMI) database, we investigated the longitudinal association of PD-associated polygenic load with changes in striatal dopaminergic activity as measured by 123I-N-3-fluoropropyl-2-β-carboxymethoxy-3β-(4-iodophenyl) nortropane (123I-FP-CIT) SPECT over 4 years. PD-associated polygenic load was estimated by calculating weighted genetic risk scores (GRS) using 1) all available 27 PD-risk single nucleotide polymorphisms (SNPs) in the PPMI database (GRS1) and 2) 23 SNPs with minor allele frequency >0.05 (GRS2). RESULTS: GRS1 and GRS2 were correlated with younger age at onset in patients with PD (GRS1, Spearman ρ = -0.128, p = 0.019; GRS2, Spearman ρ = -0.109, p = 0.047). Although GRS1 did not show an association with changes in striatal 123I-FP-CIT availability, GRS2 was associated with a slower decline of striatal dopaminergic activity (interactions with disease duration in linear mixed model; caudate nucleus, estimate = 0.399, SE = 0.165, p = 0.028; putamen, estimate = 0.396, SE = 0.137, p = 0.016). CONCLUSIONS: Our results suggest that genetic factors for PD risk may have heterogeneous effects on striatal dopaminergic degeneration, and some factors may be associated with a slower decline of dopaminergic activity. Composition of PD progression-specific GRS may be useful in predicting disease progression in patients.
引用
- Lee MJ, Pak K, Kim JH, et al. Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease. Neurology. 2019. PMID: 31289143. doi:10.1212/WNL.0000000000007939
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。